Entrar Registro gratuito

Albireo Pharma Inc Renda

Qual é o Renda de Albireo Pharma Inc?

O Renda de Albireo Pharma Inc é -$131.15

Qual é a definição de Renda?

Lucro Líquido Disponível para os Acionistas Ordinários é igual ao lucro líquido menos os dividendos preferenciais pagos.

Net income available to common shareholders are the profits remaining after the company pays all of its suppliers, employees, service providers, creditors, and preferred shareholders. In other words, this is revenue less all expenses and preferred dividends. The number measures common shareholders' claim on the company's cash flows.

Renda de empresas na Setor Health Care em NASDAQ em comparação com Albireo Pharma Inc

O que Albireo Pharma Inc faz?

Albireo Pharma is a clinical-stage biopharmaceutical company focused on the development of novel bile acid modulators to treat rare pediatric and adult liver diseases, and other adult liver diseases and disorders. Albireo's lead product candidate, odevixibat, is being developed to treat rare pediatric cholestatic liver diseases with Phase 3 pivotal trials in PFIC, Alagille syndrome and biliary atresia. The Company completed IND-enabling studies for new preclinical candidate A3907 this year and plans to advance development in adult liver disease. Albireo was spun out from AstraZeneca in 2008 and is headquartered in Boston, Massachusetts, with its key operating subsidiary in Gothenburg, Sweden. The Boston Business Journal named Albireo one of the 2020 Best Places to Work in Massachusetts for the second consecutive year.

Empresas com renda semelhantes a Albireo Pharma Inc